Form 4: Mural Oncology Director Sachiyo Minegishi Acquires Stock Options
SEC Form 4 Filing
Director Sachiyo Minegishi of Mural Oncology plc reports the acquisition of stock options.
Summary
- Sachiyo Minegishi, a director of Mural Oncology plc, filed a Form 4 disclosing a transaction.
- The transaction involved the acquisition of 15,335 stock options on September 20, 2024, at an exercise price of $3.38.
- The options vest in 12 equal quarterly installments over three years from the grant date and expire on September 19, 2034.
- Following the transaction, Minegishi directly owns 15,335 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's securities.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | Date of the stock option grant and transaction. |
| 09/19/2034 | Expiration date of the stock options. |
| 09/23/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.